Back to search results

Digital Health App for Lung Cancer Survivors

This study is testing a digital health app called PROMOTE to help people with advanced lung cancer improve their physical health and overall well-being. The app offers educational modules on topics like physical activity, managing breathlessness, sleep, and nutrition. You might receive the PROMOTE app or standard care along with health education materials from the American Cancer Society. Researchers want to see if the PROMOTE app helps improve how you feel physically after 12 weeks. This study is for adults aged 18 and older who have stage I-III non-small cell lung cancer and are starting treatment with chemotherapy, possibly with immunotherapy, with the goal of cure. The current status of recruitment for this study is unclear.

Study design
This is an interventional study planning to enroll 250 participants. It compares the PROMOTE digital health app to enhanced usual care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, patient-reported physical function, is measured at 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07227623

A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors

Recruiting
NAAges 18+InterventionalSupportive care
Massachusetts General Hospital
~250 participants
Updated 2026-03-19 on ClinicalTrials.gov
What's tested:PROMOTE Digital Health App InterventionEnhanced Usual Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-reported Physical Function
Measured over 12 weeks

Conditions

Advanced Lung Cancer
Physical Function

Explore related trials

Lung Non-Small Cell Carcinoma

Where it's being run

1 sites across 1 states
Massachusetts1

Who to contact

Joseph A. Greer, PhD
[email protected]
617-643-2143
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years
Diagnosis of stage I-III non-small cell lung cancer
Within six weeks of initiating treatment with curative intent that includes chemotherapy ± immunotherapy in the neo-adjuvant or adjuvant setting with surgery or as part of definitive chemoradiation
Eastern Cooperative Oncology Group Performance Status = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours)
Ability to use a digital health intervention that includes verbal and written information in English
Ability to complete questionnaires in English or Spanish
Primary cancer care at one of the participating institutions

Exclusion

Significant uncontrolled psychiatric disorder or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the patient's ability to participate in study procedures

What this trial measures

  • Patient-reported Physical Function12 weeks

    To compare patient-reported physical function at 12 weeks using the PROMIS Physical Function 8b Short Form, which is an 8-item measure that evaluates self-perceived capability of one's upper extremities, lower extremities, and activities of daily living (total scale score range: 8-40), with higher scores indicating better functioning.